ProfileGDS4718 / 229264_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 48% 62% 65% 45% 57% 73% 63% 58% 56% 54% 53% 63% 57% 65% 62% 56% 63% 66% 72% 85% 51% 55% 53% 61% 50% 72% 49% 77% 43% 59% 70% 70% 50% 56% 70% 59% 68% 63% 57% 66% 52% 63% 70% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4053648
GSM549102patient 115, normal, homogenized [OPG study]6.2677262
GSM549104patient 119, normal, homogenized [OPG study]6.5427265
GSM549108patient 138, normal, homogenized [OPG study]5.3112245
GSM549119patient 077, normal, homogenized [OPG study]5.9181357
GSM549133patient 032, cancer, homogenized [OPG study]7.1910373
GSM549139patient 042, cancer, homogenized [OPG study]6.3066163
GSM549099patient 107, normal, homogenized [OPG study]5.9647458
GSM549109patient 139, normal, homogenized [OPG study]5.9096156
GSM549110patient 046, normal, homogenized [OPG study]5.7583854
GSM549114patient 063, normal, homogenized [OPG study]5.6588653
GSM549122patient 082, normal, homogenized [OPG study]6.3204863
GSM549134patient 033, cancer, homogenized [OPG study]5.8985157
GSM549136patient 036, cancer, homogenized [OPG study]6.4780765
GSM549140patient 044, cancer, homogenized [OPG study]6.2244362
GSM549111patient 047, normal, homogenized [OPG study]5.885456
GSM549113patient 057, normal, homogenized [OPG study]6.3245463
GSM549132patient 031, cancer, homogenized [OPG study]6.5949466
GSM549137patient 038, cancer, homogenized [OPG study]7.0416472
GSM549142patient 047, cancer, homogenized [OPG study]8.111285
GSM549100patient 110, normal, homogenized [OPG study]5.6034751
GSM549107patient 135, normal, homogenized [OPG study]5.7577555
GSM549115patient 068, normal, homogenized [OPG study]5.609653
GSM549116patient 072, normal, homogenized [OPG study]6.2174661
GSM549120patient 078, normal, homogenized [OPG study]5.5036250
GSM549131patient 030, cancer, homogenized [OPG study]7.1433672
GSM549118patient 074, normal, homogenized [OPG study]5.4317549
GSM549129patient 027, cancer, homogenized [OPG study]7.619177
GSM549123patient 088, normal, homogenized [OPG study]5.1173343
GSM549124patient 006, cancer, homogenized [OPG study]6.0836459
GSM549126patient 015, cancer, homogenized [OPG study]6.8413770
GSM549128patient 025, cancer, homogenized [OPG study]6.9574270
GSM549103patient 117, normal, homogenized [OPG study]5.5674650
GSM549117patient 073, normal, homogenized [OPG study]5.82156
GSM549138patient 041, cancer, homogenized [OPG study]6.9270970
GSM549141patient 045, cancer, homogenized [OPG study]6.0664959
GSM549130patient 028, cancer, homogenized [OPG study]6.6780168
GSM549101patient 111, normal, homogenized [OPG study]6.3346163
GSM549105patient 128, normal, homogenized [OPG study]5.9406857
GSM549106patient 134, normal, homogenized [OPG study]6.5733466
GSM549112patient 048, normal, homogenized [OPG study]5.6471352
GSM549125patient 011, cancer, homogenized [OPG study]6.3513563
GSM549127patient 024, cancer, homogenized [OPG study]6.947870
GSM549135patient 035, cancer, homogenized [OPG study]8.0408981